White House Reportedly Opposes FDA's Guidelines Endangering Pre-Election Release of COVID-19 Vaccine | WHAT REALLY HAPPENED

White House Reportedly Opposes FDA's Guidelines Endangering Pre-Election Release of COVID-19 Vaccine

Despite being non-binding, these guidelines are still capable of thwarting the hopes of US President Donald Trump, who has repeatedly hinted that a COVID-19 vaccine might hit the shelves before the November election.

The White House has been blocking the release of new guidelines for the emergency authorisation of vaccines, penned by the Food and Drug Administration (FDA) for two weeks now, as several biotech companies are approaching the end of COVID-19 trials, The New York Times reported, citing anonymous sources.

The new set of guidelines, which is a non-binding document outlining recommendations for pharmaceutical companies, reportedly suggests that trial subjects must be observed for two months after the last injection of a drug to ensure its safety and efficiency. The document was submitted by the FDA to the Office of Management and Budget for a review on 21 September, but has since been blocked by White House Chief of Staff Mark Meadows, The New York Times sources claimed.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA